Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JNJ | NVO | MRK | ||
| Company | Johnson & Johnson | Novo Nordisk A/S ADR | Merck & Company | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 148.14 | 127.16 | 126.82 | ||
| High | 148.99 | 127.32 | 127.59 | ||
| Low | 146.86 | 125.35 | 125.35 | ||
| Last | 148.53 | 126.16 | 127.00 | ||
| Change | -1.03 | -2.48 | +0.12 | ||
| % Change | -0.69% | -1.93% | +0.09% | ||
| Volume | 9,602,000 | 3,092,010 | 7,085,216 | ||
| 20-Day Average Volume | 8,070,900 | 3,512,985 | 7,185,284 | ||
| Previous Close | 149.56 | 128.64 | 126.88 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 150.94 | 125.59 | 127.55 | ||
| 20-Day Raw Stochastic | 33.73% | 52.21% | 29.07% | ||
| 20-Day Relative Strength | 39.24% | 51.83% | 54.70% | ||
| Weighted Alpha | -10.52 | +54.54 | +15.16 | ||
| Today's Opinion | 100% Sell | 56% Buy | 88% Buy | ||
| Previous Opinion | 88% Sell | 72% Buy | 88% Buy | ||
| Last Month's Opinion | 40% Sell | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.60% since 04/17/24 | +1.31% since 04/17/24 | +1.30% since 04/17/24 | ||
| Low | 143.13 on 04/18/24 | 122.46 on 04/19/24 | 124.50 on 04/18/24 | ||
| High | 150.49 on 04/23/24 | 128.76 on 04/23/24 | 128.10 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -4.32% since 03/22/24 | -2.02% since 03/22/24 | +2.54% since 03/22/24 | ||
| Low | 143.13 on 04/18/24 | 121.79 on 04/16/24 | 123.77 on 03/25/24 | ||
| High | 159.14 on 03/28/24 | 130.25 on 03/25/24 | 133.10 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | -6.56% since 01/24/24 | +19.91% since 01/24/24 | +6.83% since 01/24/24 | ||
| Low | 143.13 on 04/18/24 | 104.81 on 01/25/24 | 118.66 on 01/25/24 | ||
| High | 163.11 on 03/12/24 | 138.28 on 03/07/24 | 133.10 on 03/27/24 | ||
| 6-Month | |||||
| %Chg | -1.79% since 10/24/23 | +29.37% since 10/24/23 | +23.27% since 10/24/23 | ||
| Low | 143.13 on 04/18/24 | 92.94 on 10/27/23 | 99.80 on 11/29/23 | ||
| High | 163.58 on 01/22/24 | 138.28 on 03/07/24 | 133.10 on 03/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 360,407,104 | 577,276,160 | 321,390,592 | ||
| Shares Outstanding, K | 2,409,783 | 4,487,532 | 2,533,028 | ||
| Annual Sales | 85,159,000,000 | 33,724,300,000 | 60,115,000,000 | ||
| Annual Net Income | 35,153,000,000 | 12,150,770,000 | 365,000,000 | ||
| Last Quarter Sales | 21,383,000,000 | 9,526,160,000 | 14,631,000,000 | ||
| Last Quarter Net Income | 5,354,000,000 | 3,175,360,000 | -1,226,000,000 | ||
| 60-Month Beta | 0.53 | 0.41 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.71 on 04/16/24 | 0.71 on 01/31/24 | 0.03 on 02/01/24 | ||
| Latest Earnings Date | 04/16/24 | 05/02/24 | 04/25/24 | ||
| Most Recent Dividend | 1.190 on 02/16/24 | 0.663 on 03/22/24 | 0.770 on 03/14/24 | ||
| Next Ex-Dividends Date | 05/20/24 | 03/22/24 | 03/14/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 14.26 | 46.31 | 84.63 | ||